Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 227 entries
View as:

Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01498978 Org: User:
Start: 02/06/12 End: 01/19/19 Due: 01/19/20

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05081024 Org: User:
Start: 09/03/21 End: 09/03/25 Due: 09/03/26

Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04659616 Org: User:
Start: 01/14/21 End: 02/01/26 Due: 02/01/27

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00245037 Org: User:
Start: 06/30/05 End: 08/31/15 Due: 08/31/16

Abraxane/Bevacizumab

Phase: N/A Priority: Normal
NCT ID: NCT01821859 Org: User:
Start: 01/31/10 End: 11/30/11 Due: 11/30/12

Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03812289 Org: User:
Start: 02/07/19 End: 01/11/24 Due: 01/11/25

Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04465760 Org: User:
Start: 02/25/21 End: 11/05/21 Due: 11/05/22

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04005690 Org: User:
Start: 08/01/19 End: 02/01/28 Due: 02/01/29

Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study

Phase: N/A Priority: Normal
NCT ID: NCT04993313 Org: User:
Start: 03/18/22 End: 02/28/26 Due: 02/28/27

Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02503358 Org: User:
Start: 07/21/16 End: 07/16/20 Due: 07/16/21

Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03135782 Org: User:
Start: 08/01/17 End: 09/23/20 Due: 09/23/21

Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01780701 Org: User:
Start: 01/31/13 End: 03/31/17 Due: 03/31/18

Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03234309 Org: User:
Start: 10/20/17 End: 08/30/21 Due: 08/30/22

Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06895473 Org: User:
Start: 04/01/25 End: 12/31/27 Due: 12/31/28

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06249191 Org: User:
Start: 06/13/24 End: 04/01/27 Due: 04/01/28

Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00428077 Org: User:
Start: 10/31/05 End: 04/30/09 Due: 04/30/10

Feasibility of FMISO in Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03649880 Org: User:
Start: 06/01/19 End: 01/31/30 Due: 01/31/31

Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial

Phase: N/A Priority: Normal
NCT ID: NCT06673095 Org: User:
Start: 12/11/24 End: 12/31/27 Due: 12/31/28

Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00769093 Org: User:
Start: 10/31/08 End: 07/31/14 Due: 07/31/15

War on Melanoma™ Public Health & Education Campaign

Phase: N/A Priority: Normal
NCT ID: NCT04611568 Org: User:
Start: 05/14/19 End: 12/30/25 Due: 12/30/26

Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01031953 Org: User:
Start: 08/31/08 End: 02/28/13 Due: 02/28/14

Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response

Phase: N/A Priority: Normal
NCT ID: NCT00994201 Org: User:
Start: 10/31/11 End: 06/30/15 Due: 06/30/16

CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers

Phase: N/A Priority: Normal
NCT ID: NCT02355262 Org: User:
Start: 07/01/14 End: 06/30/20 Due: 06/30/21

Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02504359 Org: User:
Start: 07/20/15 End: 09/09/20 Due: 09/09/21

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Phase: N/A Priority: Normal
NCT ID: NCT00381862 Org: User:
Start: 06/30/06 End: 07/31/08 Due: 07/31/09